The International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, launched World Cancer Report 2014, a collaboration of over 250 leading scientists from more than 40 countries, describing multiple aspects of cancer research and control.

Read more...

ISOPP

2014 REQUEST FOR PROPOSALS

We invite all ISOPP members at universities, hospitals and research institutions, to submit applications for research grants focused on oncology pharmacy research in pre-clinical, clinical, translational or practice related areas.

Potential applicants should submit electronically the required administrative information and a Letter of Intent addressed to the Research Committee Chair summarizing the proposed studies via our online system at http://www.isopp.org under the research grant tab. On line submission process will begin, Friday January 31st 2014 with DEADLINE/submission link closing on Monday March 10th 2014 at 5 PM (CST).

Eligibility:  All applicants must be an active member of ISOPP defined as:

1. Active ISOPP membership for greater than one (1) year.
2. Attended at least one ISOPP symposium Annual Meeting within past five (5) years (or registered to attend upcoming meeting). [Note Committee will confirm with ISOPP Administrative Staff]
3. Not previously received research funding support from ISOPP.  (previous awardees are not eligible)
4. Be able to provide letter of support from Director Supervisor or Institutional Official confirming dedicated time to conduct study will be allowed.
5. Project can be completed in less than 2 years for final results to be presented at ISOPP XV meeting in 2016.

The Grant Application must include the following information in this order:
*Be sure to follow page limits- exceeding page limits will lead to automatic “rejection” of application.* 

1. Title and study abstract (1/2 page limit)
2. Key personnel/Research collaborators with role/contributions in project  (1 page limit)
3. Specific Aims (study objectives) and the hypothesis or hypotheses to be tested (1 page limit)
4. The relevance to oncology pharmacy practice and ISOPP mission. (1/2 page limit)
5. Brief background (1 and 1/2 page limit)
6. Preliminary data (if available)
7. Research Plan (2 page limit)
   1. A brief description of the study methods
      1. If human subjects or animal study MUST provide letter of protocol approval with application.  If “pending approval” funds will not be awarded until documentation of approval is provided.
   2.  Data Analysis
      1. A plan for evaluating the results
      2. Include statistical justifications for study numbers/design
8. Detailed study budget including personnel, supplies, services, and/or equipment funds requested.  Salary support for principal investigator is not allowed.  NO indirect charges/fees will be covered.  There is a total of 15,000 euros available to fund these grant applications and we plan on awarding at from one to up to three grants for this year.  Grants could be partially funded. (1 page limit)
9. Budget justification: provide brief explanation for funds.  For example percent effort for personnel expenses and services or equipment expenses need clear justification. (1 page limit)
10. Current financial support: list each current grant or contract for the conduct of this research. If there are no other grants, state "NONE". (not included in page limits)
11. A biographical sketch/curriculum vitae or resume for Principal Investigator and any key personnel (4 page limit)
12. Letter of support from Direct Supervisor/Institutional Official (not included in page limits)
13. References/Citations (not included in page limits)

The online process must be completed by DEADLINE on Monday, March 10th, 2014 at 5:00 PM (CST).

All file attachments should be submitted as a "PDF" file. Other formats will be rejected.

The applications will be evaluated by the ISOPP Research Committee and/or selected ISOPP members within area of similar areas research. Our decision will be transmitted to the candidates no later than Friday March 28^th 2014 and Research Awards will officially be presented at the ISOPP XIV Annual Conference, April 2nd – 5^th in Montreal, Canada during the ISOPP Business Meeting. Awardee should make every effort to attend. Funding will be initiated in July 2014. All awardees will be required to present completed study results at ISOPP XV meeting in 2016.

Any questions or clarifications need, please contact the Research Committee Chair, Judith Smith at This e-mail address is being protected from spambots. You need JavaScript enabled to view it (713)-500-6408.

ISOPP's December Newsletter is now posted on the website.

John Wiernikowski, President ISOPP 2012 - 2014
Jillian Davis, Newsletter Editor

INTERNATIONAL SOCIETY OF ONCOLOGY
PHARMACY PRACTITIONERS

INTERNATIONAL TRAVEL GRANTS PROGRAM
ISOPP XIV, April 2-5, 2014, Montreal, Canada

We are pleased to offer the ISOPP International Travel Grants Program to attend ISOPP XIV in Montreal, Quebec, Canada from April 2 to 5, 2014.  Up to FIVE travel grants of €1250 Euro each are available for members who have paid their 2014 membership fees.

How to Apply:
Please fill in and submit the ISOPP XIV Travel Grant Application form, found at the bottom of this page and send it) to Jill Kolesar, Chair ISOPP Membership Committee via email at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Deadline:
Application deadline is Friday, January 10, 2014.

Responsibilities of Recipients:
The responsibilities of recipients are to:

•  attend at the General Assembly and be introduced at the meeting
•  submit a 1000 word article describing their practice and how attending the ISOPP meeting will be applied to their practice for publication in the ISOPP Newsletter

Reimbursement of Expenses:
The recipient will be reimbursed to a maximum of €1250 Euros by wire transfer after the ISOPP meeting and upon receipt of the ISOPP Newsletter article.  Expense receipts are required and if less than the specified amount is spent, the grant recipient will only be reimbursed for their total expenses.

Review Process:
The review process is as follows:

•  Applications will be reviewed by the Membership Committee and notification of travel awards will be made via email by January 16, 2014.
• Receipt of applications will be acknowledged electronically (by e-mail).
• Applicants are advised to determine entry VISA requirements and apply early if required.

Jill Kolesar
Chair ISOPP Membership Committee
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

On 6 September 2013 the EMA granted marketing authorisation for the medicinal product containing autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-T). Provenge is indicated for treatment of asymptomatic or minimally symptomatic metastatic (non-visceral) castrate-resistant prostate cancer in male adults in whom chemotherapy is not yet clinically indicated. The medicine is under additional monitoring. The holder of marketing authorisation is Dendreon UK Ltd.

Read more...

On 16 October 2013 the Committee for Medicinal Products for Human Use (CHMP) granted a marketing authorisation for the medicinal product GIOTRIF (afatinib) 20 mg film coated tablets intended for the treatment of EGFR TKI-naive adult patients with locally advanced or metastatic NSCLC with activating EGFR mutations. The holder of the marketing authorisation is Boehringer Ingelheim International GmbH.

Read more...

In 2003, SIGN published a guideline on the management of epithelial ovarian cancer (SIGN 75) and since then new evidence has been published in many areas covered by the recommendations in that guideline resulting in the need for this selective update. 

Read more...

Read more...

Read more...

Read more...

To view the October 2013 Newsletter, click on the attachment below.

 Jill Davis

ISOPP Newsletter Editor

Between 1st and 31st October 2013, all SAGE content, including Journal of Oncology Pharmacy Practice, is FREE to view online.

Read more...

Read more...

Do your patients use CAMS (complementary and alternative medicines)?

Do you need to know more about them?

COSA (the Clinical Oncological Society of Australia) has produced a position statement to improve our knowledge of CAMS, produce guidelines for practice, to highlight specific issues in oncology and how to manage unconventional treatments. This position statement also contains numerous references for further reading. Provided here for ISOPP members, with permission from COSA, this Position Statement will assist you to deal more effectively with CAM use in your patients. 

ISOPP XIV 2014 Symposium
Wednesday-Saturday, April 2-5th, 2014
 Montreal, Quebec, Canada
CALL FOR ABSTRACTS

ABSTRACT DEADLINES
Monday, December 2, 2013 (11:59 USA, PST): Abstracts must describe completed research (ie, abstracts that contain objective, methods, results and conclusions). All accepted abstracts will be published in an issue of the Journal of Oncology Pharmacy Practice. Accepted abstracts will be notified by December 9, 2013. Please refer to the ISOPP website for helpful hints/suggestions and sample of an abstract and poster under the abstract submission tab.

ONLINE SUBMISSION PROCESS
Abstracts may be submitted starting September 25, 2013.  Anyone may submit an abstract for the 2014 meeting.  If you are not a member of ISOPP, you will have to register on the website to have access to the abstract submission form.  (The register button is on the top right hand corner of the website). If you are a member of ISOPP, log in on line and then go through the submission process.  Questions or problems can be directed to ISOPP Research Committee Chair, Judith A. Smith at 001-713-500-6408 or at email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Abstract acceptance notices will be sent out on December 20, 2013.

Thank You!
Judith A. Smith, Pharm.D., BCOP
Chair,
ISOPP Research Committee

Click here to go to Abstract Submission 

Read more...

Click here to go to the event page

Read more...

The early bird registration deadline for the Australasian ISOPP Symposium 2013 is July 1^st!

The Australasian ISOPP Symposium 2013 will take place on August 10-11, 2013 in Fitzroy, Victoria, Australia.

Register by the early bird deadline of Monday, July 1^st to save on your registration fee.

Click here to register.

Click here to view the Symposium programme.

Click here to access the Calendar of Events.